Increased levels of PAI-1 were indicated to predict poor clinical outcomes in various types of cancers, including gastric [11,12], breast [13], ovarian [14,15], and lung cancer [16,17], showing the paradoxical functions of PAI-1 in tumor progression. The gene discussed is SERPINE1; the disease is cancer.